Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 150

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 150
---
’ deferred commissions (or up to $10,950,000        
 if the underwriters’ option to purchase additional units is exercised in full) will               
 be paid to the underwriters from the funds held in the trust account, and the remaining funds,    
 less amounts released to the trustee to pay redeeming shareholders, will be released to us        
 and can be used to pay all or a portion of the purchase price of the business or businesses       
 with which our initial business combination occurs or for general corporate purposes, including   
 payment of principal or interest on indebtedness incurred in connection with our initial          
 business combination, to fund the purchases of other companies, or for working capital. The       
 underwriters will not be entitled to any interest accrued on the deferred underwriting discounts  
 and commissions.                                                                                  |

<div align='center'>81</div>

| (4) | These expenses are estimates only. Our actual                                                      
 expenditures for some or all of these items may differ from the estimates set forth herein.        
 For example, we may incur greater legal and accounting expenses than our current estimates         
 in connection with negotiating and structuring our initial business combination based upon         
 the level of complexity of such business combination. In the event we identify a business          
 combination target in a specific industry subject to specific regulations, we may incur additional 
 expenses associated with legal due diligence and the engagement of special legal counsel.          
 In addition, our staffing needs may vary and as a result, we may engage a number of consultants    
 to assist with legal and financial due diligence. We do not anticipate any change in our           
 intended use of proceeds, other than fluctuations among the current categories of allocated        
 expenses, which fluctuations, to the extent they exceed current estimates for any specific         
 category of expenses, would not be available for our expenses. The amount in the table above       
 does not include interest available to us from the trust account.                                  |

| (5) | The estimate for office space and administrative                                                  
 support is for twelve (12) months only. Nasdaq rules provide that at least 90%                    
 of the gross proceeds from this offering and the sale of the private placement warrants be        
 deposited in a trust account. Of the $206,000,000 in gross proceeds we receive from this          
 offering and the sale of the private placement warrants described in this prospectus, or          
 $236,000,000 if the underwriters’ over-allotment option is exercised in full, $200,000,000        
 ($10.00 per unit), or $230